Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

Author： Roché Henri  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.125, Iss.3, 2011-02, pp. : 755-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

By Hortobagyi Gabriel   Gomez Henry   Li Rubi   Chung Hyun-Cheol   Fein Luis   Chan Valorie   Jassem Jacek   Lerzo Guillermo   Pivot Xavier   Hurtado de Mendoza Fernando   Xu Binghe   Vahdat Linda   Peck Ronald   Mukhopadhyay Pralay   Roché Henri  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 409-418

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

By Osako Tomo   Ito Yoshinori   Takahashi Shunji   Tokudome Nahomi   Iwase Takuji   Hatake Kiyohiko  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 159-164

Springer Publishing Company

Access to resources Recommend Favorite

Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer

By Li Lun   Li Jiang   Yang Kehu   Tian Jinhui   Sun Tiantian   Jia Wenqin   Zhang Peng   Yi Kang  

Future Oncology, Vol. 6, Iss. 2, 2010-02 ,pp. : 201-207

Future Medicine

Access to resources Recommend Favorite

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes

By Awada A.   Biganzoli L.   Cufer T.   Beex L.   Lohrisch C.   Batter V.   Hamilton A.   Nooij M.   Piccart M.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 773-778

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program

By Pierga J. Y.   Fumoleau P.   Brewer Y.   Zelek L.   Martin D.   Turpin F. L.   Goudier M. J.   Gil-delgado M.   Baticle J. L.   Namer M.   Chollet P.   Sutherland W.   Barats J. C.  

Breast Cancer Research and Treatment, Vol. 88, Iss. 2, 2004-11 ,pp. : 117-129

Springer Publishing Company

Access to resources Recommend Favorite